CNOBP
ConnectOne Bancorp, Inc.
$24.79
+0.16%
$1.2B
No data for this timeframe.
Vol
Market Cap$1.2B
Cap SizeSmall Cap
SEC Reports3
Recent Activity
May 20, 2026
SEC
ConnectOne Bancorp filed an 8-K reporting the internal promotion of Elizabeth Magennis to President of the Registrant (s
8-K — Impact 2/10
Apr 23, 2026
SEC
ConnectOne Bancorp reported Q1 2026 earnings with diluted EPS of $0.72, missing the consensus of $0.79. Net interest mar
8-K — Impact 5/10
Apr 9, 2026
SEC
ConnectOne Bancorp announced it will release its first-quarter 2026 financial results on April 23, 2026, followed by a c
8-K — Impact 3/10
Analyst Ratings
4Strong Buy
6Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
2/10
ConnectOne Bancorp filed an 8-K reporting the internal promotion of Elizabeth Magennis to President of the Registrant (s
May 20, 2026
NEUTRAL
8-K
5/10
ConnectOne Bancorp reported Q1 2026 earnings with diluted EPS of $0.72, missing the consensus of $0.79. Net interest mar
Apr 23, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.3/10.
NEUTRAL
8-K
2/10
ConnectOne Bancorp filed an 8-K reporting the internal promotion of Elizabeth Magennis to President
May 20, 2026
NEUTRAL
8-K
5/10
ConnectOne Bancorp reported Q1 2026 earnings with diluted EPS of $0.72, missing the consensus of $0.
Apr 23, 2026
NEUTRAL
8-K
3/10
ConnectOne Bancorp announced it will release its first-quarter 2026 financial results on April 23, 2
Apr 9, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 91% buy across 11 analysts — 4 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 52.3% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 11.5% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.5B | 29.0% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.5B | 7.9% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 4 | 6 | 1 | 0 | 0 | 91% | |
| Apr 1, 2026 | 4 | 6 | 1 | 0 | 0 | 91% | |
| Mar 1, 2026 | 4 | 6 | 1 | 0 | 0 | 91% | |
| Feb 1, 2026 | 4 | 6 | 1 | 0 | 0 | 91% | |
| Jan 1, 2026 | 4 | 6 | 1 | 0 | 0 | 91% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.